Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Smith

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Echocardiography (Mount Kisco, N.Y.)|March 9, 2002
Multicenter evaluation of SonoVue for improved endocardial border delineationNavin C Nanda, Daniel C Wistran, Ronald P Karlsberg, et al.
Journal of the American Society of Hypertension : JASH|December 7, 2010
Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressureRhonda Kaufman, Irene Nunes, James A Bolognese, et al.
Journal of Clinical Pharmacology|September 21, 2005
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunctionMary F Hebert, Helen E Smith, Thomas C Marbury, et al.
British Journal of Clinical Pharmacology|March 4, 2011
The pharmacokinetics of PF-734200, a DPP-IV inhibitor, in subjects with renal insufficiencyHaiqing Dai, Susan L Johnson, Steven G Terra, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studiesAlison E Heald, Patrick L Iversen, Jay B Saoud, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Development of a Potent and Selective HDAC8 InhibitorOscar J Ingham, Ronald M Paranal, William B Smith, et al.
Journal of the American College of Cardiology|November 16, 2005
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trialRalph M Vicari, Bernard Chaitman, Deborah Keefe, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2025
Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trialYizhe Chen, Richard A Preston, Thomas Marbury, et al.
The American Journal of Cardiology|January 24, 2007
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic functionJalal K Ghali, William B Smith, Guillermo Torre-Amione, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2014
7,9-Diaryl-1,6,8-trioxaspiro[4.5]dec-3-en-2-ones: readily accessible and highly potent anticancer compoundsMichael P D'Erasmo, William B Smith, Alberto Munoz, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Echocardiography (Mount Kisco, N.Y.)|March 9, 2002
Multicenter evaluation of SonoVue for improved endocardial border delineationNavin C Nanda, Daniel C Wistran, Ronald P Karlsberg, et al.
Journal of the American Society of Hypertension : JASH|December 7, 2010
Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressureRhonda Kaufman, Irene Nunes, James A Bolognese, et al.
Journal of Clinical Pharmacology|September 21, 2005
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunctionMary F Hebert, Helen E Smith, Thomas C Marbury, et al.
British Journal of Clinical Pharmacology|March 4, 2011
The pharmacokinetics of PF-734200, a DPP-IV inhibitor, in subjects with renal insufficiencyHaiqing Dai, Susan L Johnson, Steven G Terra, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studiesAlison E Heald, Patrick L Iversen, Jay B Saoud, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Development of a Potent and Selective HDAC8 InhibitorOscar J Ingham, Ronald M Paranal, William B Smith, et al.
Journal of the American College of Cardiology|November 16, 2005
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trialRalph M Vicari, Bernard Chaitman, Deborah Keefe, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2025
Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trialYizhe Chen, Richard A Preston, Thomas Marbury, et al.
The American Journal of Cardiology|January 24, 2007
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic functionJalal K Ghali, William B Smith, Guillermo Torre-Amione, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2014
7,9-Diaryl-1,6,8-trioxaspiro[4.5]dec-3-en-2-ones: readily accessible and highly potent anticancer compoundsMichael P D'Erasmo, William B Smith, Alberto Munoz, et al.
Pageof 11